Method for inhibiting cancer metastasis by oral administration of soluble modified citrus pectin
US5834442A · kind A · utility
40Cited by
9References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 7, 1994 |
| Grant date | Nov 10, 1998 |
| Priority date | — |
| Expiry date | Jul 7, 2014 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for the treatment of cancer in mammals. A subject afflicted with cancer receives by oral administration a pH modified citrus pectin which inhibits metastasis of primary tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.